Apogee Therapeutics, BitFuFu rise premarket; AbbVie gains after deal

Investing.com Gold reports: Apogee Therapeutics, BitFuFu rise premarket; AbbVie gains after deal. Full body text was unavailable at ingest time, so this brief is based on headline context.